Page last updated: 2024-08-23

raloxifene hydrochloride and leptin

raloxifene hydrochloride has been researched along with leptin in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (83.33)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eng-Wong, J; Hursting, SD; Perkins, SN; Venzon, D; Zujewski, JA	1
Bonn, D	1
Coppola, A; Di Carlo, C; Di Carlo, R; Esposito, E; Meli, R; Nappi, C; Nasti, A; Pacilio, M; Raso, GM	1
Altunyurt, S; Cakmak, A; Caliskan, S; Dogan, E; Guclu, S; Posaci, C	1
Alexandrou, AP; Christodoulakos, GE; Creatsas, GC; Economou, EV; Kouskouni, EE; Lambrinoudaki, IV; Panoulis, CP; Vlachou, SA	1
Alonso-Garcia, G; Fernández-García, D; Mezquita-Raya, P; Muñoz-Torres, M; Reyes-García, R; Rozas-Moreno, P; Sebastián-Ochoa, A	1

Trials

2 trial(s) available for raloxifene hydrochloride and leptin

Article	Year
Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2003, Volume: 12, Issue:12 Topics: Administration, Oral; Adult; Age Factors; Biomarkers, Tumor; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Leptin; Middle Aged; Pilot Projects; Premenopause; Probability; Raloxifene Hydrochloride; Risk Assessment; Sensitivity and Specificity; Statistics, Nonparametric	2003
Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene. Maturitas, 2008, Jan-20, Volume: 59, Issue:1 Topics: Adult; Body Mass Index; Contraceptives, Oral, Synthetic; Estradiol; Estrogen Receptor Modulators; Estrogens; Estrogens, Conjugated (USP); Fas Ligand Protein; Female; Follicle Stimulating Hormone; Ghrelin; Hormone Replacement Therapy; Humans; Insulin; Leptin; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Sex Hormone-Binding Globulin	2008

Article

Year

Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2003, Volume: 12, Issue:12

Topics: Administration, Oral; Adult; Age Factors; Biomarkers, Tumor; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Leptin; Middle Aged; Pilot Projects; Premenopause; Probability; Raloxifene Hydrochloride; Risk Assessment; Sensitivity and Specificity; Statistics, Nonparametric

2003

Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.

Maturitas, 2008, Jan-20, Volume: 59, Issue:1

Topics: Adult; Body Mass Index; Contraceptives, Oral, Synthetic; Estradiol; Estrogen Receptor Modulators; Estrogens; Estrogens, Conjugated (USP); Fas Ligand Protein; Female; Follicle Stimulating Hormone; Ghrelin; Hormone Replacement Therapy; Humans; Insulin; Leptin; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Sex Hormone-Binding Globulin

2008

Other Studies

4 other study(ies) available for raloxifene hydrochloride and leptin

Article	Year
New ways with old bones. Osteoporosis researchers look for drugs to replace hormone replacement therapy. Lancet (London, England), 2004, Mar-06, Volume: 363, Issue:9411 Topics: Antioxidants; Bone Resorption; Carrier Proteins; Contraindications; Female; Hormone Replacement Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isoflavones; Leptin; Membrane Glycoproteins; Osteoporosis; Phytoestrogens; Plant Preparations; Raloxifene Hydrochloride; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Selective Estrogen Receptor Modulators; Teriparatide	2004
Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology, 2004, Volume: 145, Issue:7 Topics: Adaptation, Physiological; Adipose Tissue; Animals; Body Weight; Cholesterol; Estradiol; Estrogen Antagonists; Female; Hypothalamus; Leptin; Menopause; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, Leptin	2004
Raloxifene increases serum leptin levels in postmenopausal women: a prospective study. American journal of obstetrics and gynecology, 2005, Volume: 193, Issue:2 Topics: Adult; Aged; Alkaline Phosphatase; Bone and Bones; Bone Resorption; Collagen; Collagen Type I; Female; Humans; Insulin-Like Growth Factor I; Leptin; Middle Aged; Osteocalcin; Peptides; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2005
Adiponectin and leptin serum levels in osteoporotic postmenopausal women treated with raloxifene or alendronate. Menopause (New York, N.Y.), 2012, Volume: 19, Issue:2 Topics: Adiponectin; Aged; Alendronate; Body Mass Index; Bone Density; Bone Density Conservation Agents; Female; Humans; Leptin; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride	2012